These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5599473)

  • 21. Recovery from porphyria cutanea tarda with no specific therapy other than avoidance of hepatic toxins.
    Topi GC; Amantea A; Griso D
    Br J Dermatol; 1984 Jul; 111(1):75-82. PubMed ID: 6743539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of porphyria cutanea tarda with hemangioma of the liver.
    Iwamura K; Itakura M; Takahashi M
    Tokai J Exp Clin Med; 1983 May; 8(2):211-20. PubMed ID: 6658850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Data on porphyria cutanea tarda. II. Fundamental aspects (urinary & fecal) of change in porphyrin exchange].
    VENTURA S; ARESU G; LOSTIA A
    Boll Soc Ital Biol Sper; 1959 Jun; 35(12):678-81. PubMed ID: 13671189
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect.
    Felsher BF; Kushner JP
    Semin Hematol; 1977 Apr; 14(2):243-51. PubMed ID: 323986
    [No Abstract]   [Full Text] [Related]  

  • 25. [Porphyria cutanea tarda: study of the changes in porphyrin metabolism during desferrioxamine therapy].
    Mazza U; Bianco G; Fiorina L; Prato V
    Boll Soc Ital Biol Sper; 1965 Jan; 41(1):2-4. PubMed ID: 5875798
    [No Abstract]   [Full Text] [Related]  

  • 26. [Porphyria cutanea tarda. Association with scleroderma in patches "brilliant atrophy", calcinosis, hypersideremia, and immunological changes].
    Kaminsky A; Jaimovich L; Kaminsky CA; De Kaminsky AR; Asrilant M; Cammarota H
    Arch Argent Dermatol; 1967 Dec; 17(4):361-9. PubMed ID: 5611068
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical manifestations of porphyrin metabolism disorders].
    Pustovoĭt IaS; Karpova IV; Pivnik AV; Surin VL; Luk'ianenko AV; Luchinina IuA
    Ter Arkh; 2003; 75(7):68-73. PubMed ID: 12934485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intestinal absorption of iron observed in 2 cases of porphyria cutanea tarda].
    Cupella F; Pozzi U; Carena M; Schiavi A; Colombi R
    G Ital Med Lav; 1984; 6(5-6):259-60. PubMed ID: 6545217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Iron kinetics in porphyria cutanea tarda].
    Klotz H; Klotz L; Frischauf H; Schnack H
    Dermatologica; 1968; 137(2):97-106. PubMed ID: 5673997
    [No Abstract]   [Full Text] [Related]  

  • 31. [Contribution to the knowledge of iron metabolism in porphyria cutanea tarda].
    Levi L; Spinelli Ressi F; Bettinelli CA
    G Ital Dermatol Minerva Dermatol; 1967; 108(5):367-82. PubMed ID: 5633126
    [No Abstract]   [Full Text] [Related]  

  • 32. [Porphyria cutanea tarda in 3 successive generations].
    Nürnberger F
    Med Welt; 1970 Mar; 12():508-10. PubMed ID: 5444241
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the problem of iron metabolism in porphyria cutanea tarda].
    Schnack H
    Wien Z Inn Med; 1966 Nov; 47(11):447-53. PubMed ID: 6005179
    [No Abstract]   [Full Text] [Related]  

  • 34. [Phlebotomy treatment in cases of porphyria cutanea tarda].
    Lundvall O
    Lakartidningen; 1968 Jun; 65(23):2667-77. PubMed ID: 5721515
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatic aspects of cutaneous porphyria. Apropos of 21 cases].
    Barbier P; Simonis A; Dourov N; Duret RL
    Arch Belg Dermatol; 1974; 30(2):59-66. PubMed ID: 4470371
    [No Abstract]   [Full Text] [Related]  

  • 36. [2 cases of porphyria].
    Sepe O; Tecce V; Tessitore A; Valiani R
    Acta Neurol (Napoli); 1976; 31(3):306-13. PubMed ID: 1015372
    [No Abstract]   [Full Text] [Related]  

  • 37. Skin porphyrin assay in porphyria.
    Malina L; Miller V; Magnus IA
    Clin Chim Acta; 1978 Feb; 83(1-2):55-9. PubMed ID: 620469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral contraceptives causing porphyria cutanea tarda].
    Ruszczak Z; Przyk K; Prószyńska-Kuczyńska W
    Wiad Lek; 1973 Dec; 26(23):2177-80. PubMed ID: 4588417
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of griseofulvin in hereditary porphyria cutanea tarda. Investigation of porphyrins and blood lipids.
    Ziprkowski L; Szeinberg A; Crispin M; Krakowski A; Zaidman J
    Arch Dermatol; 1966 Jan; 93(1):21-7. PubMed ID: 5900697
    [No Abstract]   [Full Text] [Related]  

  • 40. [Occupational aspects of porphyria cutanea tarda].
    Gheorghiu G; Forsea D
    Berufsdermatosen; 1968 Oct; 16(5):271-7. PubMed ID: 5709380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.